Background/Aims: Increasing evidence suggests the important role of sirtuin 2 (SIRT2) in the pathology of Parkinson's disease (PD). However, the association between potential functional polymorphisms in the SIRT2 gene and PD still needs to be identified. Exploring the molecular mechanism underlying this potential association could also provide novel insights into the pathogenesis of this disorder. Methods: Bioinformatics analysis and screening were first performed to find potential microRNAs (miRNAs) that could target the SIRT2 gene, and molecular biology experiments were carried out to further identify the regulation between miRNA and SIRT2 and characterize the pivotal role of miRNA in PD models. Moreover, a clinical case-control study was performed with 304 PD patients and 312 healthy controls from the Chinese Han population to identify the possible association of single nucleotide polymorphisms (SNPs) within the miRNA binding sites of SIRT2 with the risk of PD. Results: Here, we demonstrate that miR-486-3p binds to the 3' UTR of SIRT2 and influences the translation of SIRT2. MiR-486-3p mimics can decrease the level of SIRT2 and reduce a-synuclein (α-syn)-induced aggregation and toxicity, which may contribute to the progression of PD.
Introduction
Parkinson's disease (PD), one of the most common age-related neurodegenerative disorders worldwide, is pathologically characterized by the progressive loss of dopaminergic neurons within the substantia nigra pars compacta of the midbrain and the presence of Lewy bodies (LBs), mainly composed of accumulated misfolded α-synuclein (α-syn) protein in surviving neurons [1, 2] . Genetic and environmental risk factors have recently gained increasing attention as possible causes of PD. Significant efforts based on large-scale unbiased genome-wide association studies (GWAS) of PD patients have also successfully identified a number of loci that alter an individual's susceptibility to PD [3] [4] [5] [6] [7] [8] . However, It is necessary to verify these susceptible loci and identify new susceptible loci in different populations, and translation of the genetic causes of this disease into a pathobiological understanding is largely lacking and remains controversial [9] . SIRT2, which is a NAD+-dependent deacylase, is widely involved in biological and disease processes, such as inflammation, metabolism, neurodegeneration and tumorigenesis [10] [11] [12] [13] [14] [15] . Sirtuin 2 (SIRT2) is the most abundant sirtuin in the brain and is closely associated with aging [16] . Increasing evidence has suggested an important role for SIRT2 in the pathology of PD in recent years. It has been reported that elevation of SIRT2 worsens motor impairment, while inhibition of SIRT2 diminishes striatal DA depletion and improves behavioral abnormalities in rotenone-treated rats [17] . Neurodegeneration induced by a chronic MPTP regimen is prevented by the genetic deletion of SIRT2 in mice [18] . Moreover, the inhibition of SIRT2 in cellular and Drosophila models of PD reduces α-syn-mediated toxicity [19] and also alleviates neuropathology in several models of synucleinopathy by regulating levels of α-syn acetylation, indicating the potential of SIRT2 as a therapeutic intervention for PD by targeting α-syn [20, 21] .
In the present study, we identified for the first time a novel single nucleotide polymorphism (SNP) in SIRT2 (rs2241703) associated with susceptibility to PD in the Chinese Han population. Moreover, we provided evidence that the SNP rs2241703 influences the binding efficiency between miR-486-3p and SIRT2, leading to changes in the expression levels of SIRT2, which in turn influence the neurotoxicity and aggregation of α-syn, thus potentially contributing to the progression and risk of PD.
Materials and Methods

Cell culture
The HEK293T, SH-SY5Y and U87 cell lines were obtained from the Shanghai Cell Institute Country Cell Bank (Shanghai, China). All cell lines were grown in DMEM supplemented with 10% fetal bovine serum (FBS) (Gibco, USA), 100 U/mL penicillin G and 100 μg/mL streptomycin (Sigma, USA). The cells were maintained at 37°C in a humidified 5% CO 2 incubator.
Plasmid constructs
To generate luciferase reporter constructs containing the wild-type 3' UTR region of SIRT2, 397 bp in the 3' UTR of SIRT2 was amplified and cloned into the pLUC luciferase vector using the restriction enzymes XhoI/BamHI (Promega, USA). Luciferase reporter constructs containing different rs2241703 genotypes Cellular Physiology and Biochemistry
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were generated using the QuikChange® Site-Directed Mutagenesis Kit (Stratagene, USA) employing the wild-type 3' UTR of SIRT2 as the template. SIRT2 expression constructs were generated by subcloning the coding regions of SIRT2 into the GV141 vector using the restriction enzymes XhoI/KpnI. α-syn expression constructs were generated by subcloning the coding region of α-syn into the GV230 vector using the restriction enzymes XhoI/Kpn, resulting in the fusion of an EGFP tag to the C-terminus of α-syn. The primers used are all listed in Table 1 . All constructs were verified via sequencing.
RNA extraction and quantitative real-time reverse transcription PCR (qRT-PCR)
Total RNA was extracted from peripheral blood leukocytes or cultured cells using TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. The cDNA used to examine SIRT2 was synthesized with the PrimeScript TM RT reagent kit (TaKaRa, USA) according to the manufacturer's instructions. The cDNA employed to examine miR-486-3p was synthesized using the miRcute miRNA cDNA First-Strand Synthesis Kit (TIANGEN, China) according to the manufacturer's instructions. The expression of SIRT2 was examined using SYBR® Premix Ex Taq TM II (TaKaRa, USA), and GAPDH served as an internal reference. The expression of miR-486-3p was examined using the miRcute miRNA qPCR Detection Kit (TIANGEN, China), and U6 served as an internal reference. All experiments were performed in duplicate and repeated three times. The results are presented as the fold induction, determined using the 2 -ΔΔCt method. The primers for miR-486-3p and U6 were purchased from GenePharma, China.
Western blot analysis
Western blotting was performed according to standard western blotting procedures. Cells were lysed in RIPA buffer containing protease inhibitor cocktail (Sigma) and 1 mM phenylmethyl sulfonyl fluoride (Sigma, USA). Lysates were centrifuged at 15, 000 g for 30 min at 4°C. Supernatants were collected, and protein concentrations were determined by the BCA Protein Assay Kit (Thermo, USA). Proteins were then separated via 12% SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, USA). After blocking in 5% nonfat milk, the membranes were incubated with the following primary antibodies: anti-α-tubulin (Abcam; 1:1, 000), anti-acetylated α-tubulin (CST; 1:300), anti-SIRT2 (Abcam; 1:1, 000), anti-α-synuclein (CST; 1:1, 000), and anti-GAPDH (CST; 1:1, 000). The proteins were visualized with enhanced chemiluminescence reagents (Pierce, USA). 
Evaluation of α-synuclein aggregation
To assess the effects of miR-486-3p on α-syn aggregation, we cotransfected SH-SY5Y and U87 cells with α-syn and synphilin-1 (an established paradigm that leads to inclusion formation in SY5Y and U87 cells), with or without miR-486-3p. After 48 h, the cells were fixed for 15 min with 4% formaldehyde in PBS, followed by permeabilization with 0.2% Triton X-100 for 10 min. Cells were incubated with DAPI for 1 min at room temperature and subsequently photographed by confocal microscope (TCS SP5 II, Leica).
Triton insolubility assay
For total protein extraction, cells were lysed in NP-40 buffer (Beyotime, China) supplemented with a protease inhibitor cocktail tablet (Sigma, USA). The samples were sonicated 3 times for 30 sec, with a 1-min incubation on ice between each sonication step. Proteins were separated from debris via centrifugation at 18, 000 g for 30 min at 4°C. Total protein (1 mg) from cells transiently expressing α-syn and synphilin-1, with or without miR-486-3p, for 48 h was incubated with 1% Triton X-100 on ice for 30 min. The protein fractions were separated via centrifugation at 15, 000 g for 60 min at 4°C. The soluble protein fraction was subsequently collected, and the insoluble protein fraction pellet was resuspended in 40 μL of 2% SDS TrisHCl buffer, pH 7.4, followed by sonication for 10s. The total protein and T-Insoluble fractions were loaded and resolved via SDS-PAGE and immunoblotted as described above.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde in PBS for 15 min, washed with PBS three times, and permeabilized with 0.2% Triton X-100 in PBS for 10 min. After washing with PBS again and blocking with 1% goat serum for 30 min, cells were incubated with anti-tyrosine hydroxylase antibody (abcam; 1:200) diluted in 1% goat serum at room temperature for 1 h and washed with PBS and incubated with Cy3-conjugated goat anti-rabbit IgG (EarthOx; 1:800) diluted in 1% goat serum for 1 h at room temperature. For nuclear staining, cells were incubated with DAPI for 1 min at room temperature. Cells were washed five times with PBS and analyzed under a fluorescence microscope (EVOS fl auto, life, USA). Table 2 . Moreover, the age at onset of PD and the time until diagnosis were recorded for the 221 PD patients in the PD group.
MTT assay
Genotyping
A fasting venous blood sample of 2 mL was extracted from each subject at the elbow on the morning after diagnosis and was treated with ethylenediamine tetraacetic acid dipotassium salt (EDTA-K2) to prevent coagulation. Within 1-4 h, 0.5 mL of the blood sample was added to two 1.5-mL EP tubes. Genomic DNA was isolated from peripheral blood samples using a blood Genomic DNA Extraction Kit (TIANGEN, China). The DNA was genotyped using the ABI PRISM SNapShot method (Applied Biosystems). Briefly, the SNapShot reaction was performed in a 10-mL final volume containing SNapShot Multiplex Ready Mix (5 mL), primer mix (0.02-0.6 mmol/L), and template (4 mL) consisting of the multiplex PCR products, which were purified with the QIAquick PCR Purification Kit (QIAGEN, China). The cycling program included 25 cycles of 94°C for 30 seconds, 57°C for 30 seconds, and 72°C for 40 seconds. The extension products were purified via incubation with 1 U of shrimp alkaline phosphatase (Promega, USA) for 15 minutes at 37°C and subsequent incubation at 80°C for 15 minutes to inactivate the enzyme. The purified products (0.5 mL) were mixed with 9 mL of formamide and 0.5 mL of the GeneScan-120 LIZ Size Standard (Applied Biosystems, USA) and separated via capillary electrophoresis (ABI PRISM310 Genetic Analyzer; Applied Biosystems, USA). The results were analyzed with GeneMapper 3.0 software (Applied Biosystems, USA). For quality control, random duplicate samples (5%) were run for each sequence analysis.
Statistical analysis
Genotype and allele frequencies were estimated by counting. Hardy-Weinberg equilibrium between the expected and observed genotype distributions was assessed using the Chi-square test. Allele and genotype distributions were also compared using the Chi-square test. Associations were expressed as odds ratios (OR) or risk estimates with 95% confidence intervals (CIs). The nonparametric Mann-Whitney test was employed to compare SIRT2 expression between the genotype groups. Other data were analyzed with GraphPad Prism 6 software. Results are presented as the mean± s.e.m.; the means between two groups were compared with an unpaired, two-tailed Student's t test. The means among more than two groups were determined using one-way ANOVA. P<0.05 was considered statistically significant.
Results
SIRT2 is the target of miR-486-3p, and the SNP rs2241703 influences the binding efficiency
Bioinformatics analysis (DIANA, Targetscan, PITA) was first performed to predict and analyze potential miRNAs targeting the 3' UTR of SIRT2, thenmiR-486-3p was screened as the candidate for targeting the SIRT2 gene (data not shown). Moreover, we found that the predicted miR-486-3p binding site within the 3' UTR of the SIRT2 gene included a SNP site, rs2241703. Subsequently, a luciferase reporter assay was performed to verify whether miR-486-3p binds to the 3' UTR of SIRT2 and whether the rs2241703 SNP could influence this interaction (Fig. 1A) . As shown in Fig. 1B , there was significantly reduced binding between miR-486-3p and the A allele relative to the G allele based on the reduced luciferase activity in the presence of the G allele, suggesting that miR-486-3p directly binding to the 3' UTR of the SIRT2 gene and the rs2241703 A allele alters the binding efficiency between them (Fig. 1B) .
We next investigated the effect of miR-486-3p on the endogenous expression of SIRT2 in HEK293 cells. As shown in Fig. 1C and D, when miR-486-3p was overexpressed or silenced, (Fig. 1E and F) , suggesting that miR-486-3p negatively regulates the expression of SIRT2.
The rs2241703 p o l y m o r p h i s m influences the expression level of SIRT2
Then we further evaluated the expression of SIRT2 in peripheral blood mononuclear cells (PBMCs) from PD patients and healthy controls with different genotypes to explore the possible associations between the SNPs and SIRT2 expression levels. As shown in Fig. 2A , the mRNA expression of SIRT2 was significantly higher in the PBMCs of PD patients than in those of healthy controls (P=0.0234 and P=0.0151), and the levels of miR-486-3p were lower in PD patients than in healthy controls (Fig. 2B) . Then, we subdivided the two groups by genotype. Remarkably, the mRNA expression of SIRT2 in PD patients with the GG genotype was lower than in patients with the GA and AA genotypes, while no significant difference in the expression of SIRT2 was observed between healthy controls with the GG genotype and those with the GA or AA genotype (Fig. 2C  and D) . However, for miR-486-3p, there was no significant difference among the groups (Fig.  2C and D) . This result provides the support that the presence of the A allele may influence the expression of SIRT2 and increase the risk of PD. The mRNA levels of SIRT2 after the transfection of miR-486-3p mimics, antagomirs or NC in SH-SY5Y cells determined by qRT-PCR, relative to GAPDH as the control group; (E, F) protein levels of SIRT2 after the transfection of miR-486-3p mimics, antagomirs or NC in SH-SY5Y cells were assessed by WB and and thegrey intensity analysis, relative to β-tubulin as the control group. Results are shown as the mean±s.e.m. from three experiments, **P<0.01. Differences between groups were analyzed using two-sided t tests.
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MiR-486-3p reduces α-syn inclusions and suppresses α-Syn toxicity
A recent study showed that SIRT2 governs α-syn aggregation [21] . To confirm whether miR-486-3p regulates α-syn aggregation through SIRT2, we established a α-syn aggregation model in both SH-SY5Y and U87 cells, involving the co-expression of a C-terminally modified form of α-syn with an increased propensity for aggregation and synphilin-1 (an α-syn interactor that potentiates its aggregation) in neural cells [3] . With the transfection of miR-486-3p mimics, the formation of α-syn inclusions significantly reduced, and the diffuse distribution of α-syn was restored in SH-SY5Y cells (Fig. 3A) and U87 cells (Fig.  3B) . Moreover, elevated levels of miR-486-3p also decreased insoluble α-syn aggregation, corresponding to the above results (Fig. 3C) . Notably, α-tubulin is an important substrate related to SIRT2 and has been reported to contribute to the neurotoxicity of LBs [22] . Thus, we further measured the acetylation status of α-tubulin in SH-SY5Y cells treated with miR-486-3p mimics. As expected, the overexpression of miR-486-3p significantly increased the acetylation level of α-tubulin,and this effect could be rescued by the overexpression of SIRT2 (Fig. 3D) . The above findings suggest that miR-486-3p mimics increase the acetylation level of α-tubulin by reducing the expression of SIRT2.Finally, we evaluated whether miR-486-3p could contribute to α-syn-induced neuronal injury. We established α-syn-overexpressing and MPP+-induced SH-SY5Y cells as a PD cell model. As shown in Fig. 3E , concomitant with the decrease in α-syn aggregation, miR-486-3p decreased the cytotoxicity of α-syn according to an MTT assay. Accordingly, miR-486-3p also significantly increased the number of THpositive cells in α-syn-overexpressing SH-SY5Y cells (Fig. 3F) , suggesting that elevated miR-486-3p levels rescued PD-like neuronal injury. and SIRT2 expression levels in PD patients. (A) levels of SIRT2 in PBMCs of PD patients (n=68) and healthy controls (n=31) determined by qRT-PCR, relative to GAPDH levels; (B) levels of miR-486-3p in PBMCs of PD patients (n=38) and healthy controls (n=27) determined by qRT-PCR, relative to U6 levels; (C) levels of SIRT2 in PBMCs of PD patients with the GG (n=48) and GA+AA (n=20) genotype and healthy controls with the GG (n=20) and GA+AA (n=11) genotypes at rs2241703 determined by qRT-PCR, relative to GAPDH levels; (D) levels of SIRT2 and miR-486-3p in PBMCs of PD patients with the GG (n=30) and GA+AA (n=8 ) genotype and healthy controls with the GG (n=21) and GA+AA (n=6) genotype at rs2241703 determined by qRT-PCR, relative to U6 levels. Results are shown as the mean±s.e.m. from three experiments. All P-values are from two-sided t tests.
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Demographic characteristics of PD patients and healthy controls
Based on the above results from the mechanism study, a clinical case-control study was preformed to further explore the possible association between rs2241703 and the risk of PD. A total of 304 patients diagnosed with PD and 312 unrelated genderand age-matched controls were recruited in the present study. The demographic and clinical characteristics of the study subjects are summarized in Table  2 . The mean age of the PD patients was 64.8±10.0 years, while that of the control subjects was 62.3±10.0 years. The gender (male/female) ratio was 1:0.69 in the case group and 1:0.83 in the control group. The age and gender distributions did not differ significantly between the PD patients and the controls (P=0.236 and 0.4298, respectively). Furthermore, the onset and the duration time of PD were recorded for 222 PD patients, with average values of 64.5±10.4 years and 63.8±3.90 years, respectively. 4 . Schematic illustration of the mechanism by which the rs2241703 SNP contributes to the pathological process or risk of PD. MiR-486-3p binds to the 3' UTR of SIRT2 within the rs2241703 site, and the risk allele for rs2241703 disrupts a binding site for miRNA-486-3p and then increases the translation of SIRT2. Higher levels of SIRT2 could increase α-syn-induced aggregation and toxicity and finally may contribute to the progression and risk of PD. Table 3 . Distribution of the rs2241703 polymorphisms of the SIRT2 gene between PD patients and controls
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Association of SIRT2 polymorphisms between PD cases and controls
All enrolled samples were successfully genotyped for the rs2241703 SNP, and no deviations in Hardy-Weinberg equilibrium were observed for the rs2241703 polymorphisms in the PD and control subjects (data not shown). The allele and genotype frequencies of the SIRT2 polymorphism in the entire study population are shown in Table 3 . Significant differences in the allele frequencies of the rs2241703 SNP and the dominant model between the PD cases and controls were observed (allele P=0.0472, dominant model P=0.0454), with AA+GA genotype or A allele carriers presenting a higher risk of PD. Moreover, as shown in Table 3 , the AA+GA genotype and A allele frequencies of rs2241703 in the late-onset PD (LOPD) subgroup (>60 years) differed significantly from those in the corresponding controls (P=0.0245 for the dominant model and P=0.0413 for the allele). However, no statistical ly significant differences were observed between case and control subjects of different genders ( Table 3 ), suggesting that gender is not a risk factor contributing to PD susceptibility associated with this SNP locus. In conclusion, our case-control results revealed that the rs2241703 polymorphism, located in the SIRT2 3' UTR, is significantly associated with susceptibility to PD in the Chinese Han population.
Discussion
In the present study, we reported that miR-486-3p targets SIRT2 and identified a SNP, rs2241703, within the binding site of the 3' UTR of SIRT2 that was significantly associated with PD in the Chinese Han population. Moreover, mechanically, this SNP influenced the expression level of SIRT2 by disrupting the miR-486-3p binding sites in the 3' UTR of SIRT2, and miR-486-3p influenced SITR2 levels and the aggregation and neurotoxicity of α-syn, thereby contributing to the progression and risk of PD (Fig. 4) .
It has been reported that SIRT2, as a strong deacetylase [23] [24] [25] [26] , is highly expressed in the brain and is markedly associated with aging [27, 28] ; additionally, SIRT2 was evaluated in the brains of PD patients, suggesting a potential role in PD development [29] . It has been confirmed that selective inhibitors of SIRT2 can protect against α-syn-mediated toxicity and dopaminergic cell death, both in vitro and in a Drosophila model of PD [19] . Notably, a recent study showed that α-syn can be deacetylated by SIRT2, and α-syn acetylation is a key regulatory mechanism governing aggregation and toxicity, demonstrating the potential therapeutic value of SIRT2 inhibition in synucleinopathies [21] . The present study confirmed that mimics of miR-486-3p, which acts as an inhibitor of SIRT2, could reduce the aggregation state of LBs and α-syn-induced neurotoxicity. The results provide evidence of the mechanism by which the rs2240713 locus affects PD susceptibility and reveal a potential target of miRNA for the treatment and prevention of PD.
Increasing evidence suggests that dysregulated miRNAs directly contribute to the pathogenesis of a variety of human diseases [30] [31] [32] [33] [34] . SNPs in miRNA target sites in the 3' UTR of mRNAs are referred to as polymorphisms in microRNAs and their target sites (polymiRTSs) and can affect mRNA half-life, resulting in decreased protein levels due to mRNAmiRNA interactions and increased susceptibility to many diseases [30-33, 35, 36] , including PD [33] . Two SNPs located in the 3' UTR of human α-syn, rs17016074 and rs10024743, can influence the miRNA-mediated repression of α-syn expression [34, 37] , and two other SNPs in this region, rs356165 and rs356219, have been associated with PD in different cohorts [38, 39] . Our results confirmed a new miRNA, miR-486-3p, that targeted and regulated SIRT2, and the SNP rs2241703 is located in the core miR-486-3p-binding sequence of SIRT2. The luciferase reporter assay further confirmed that this mutation significantly influenced binding affinity, suggesting that the rs2241703 SNP influences SIRT2 levels by affecting the binding efficiency of miR-486-3p to SIRT2 due to mutation from the G allele to the A allele, resulting in weakening of the inhibitory effect and high levels of SIRT2, which may contribute to a high risk of PD or accelerate the development of this disease. Furthermore, SIRT2 increased with aging [17, 28, 40] , which may explain why AA+GA genotype or A allele Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry carriers of rs2241703 showed a higher risk of LOPD than PD. However, more evidence is needed be verify this speculation. Our case-control study showed that individuals in the southern Chinese Han population carrying the AA+GA genotype or A allele of rs2241703 had a higher risk of PD/LOPD. The rs2241703 SNP has not previously been associated with this disease, and only one reported case-control study of colorectal cancer in a Chinese Han population has highlighted the rs2241703 gene polymorphism, showing a minor allele frequency (MAF)>0.05 [41] , which was consistent with our sequencing results. Notably, based on current data from the 1000 Genomes Project, we found that the rs2241703 gene polymorphism exists only in a portion of the Asian population (Chinese, Japanese, and Vietnam), showing MAF>0.05, which is one of the reasons why GWASs conducted in Caucasian populations have not identified this SNP as being associated with a risk of PD [42] . Furthermore, as a large number of SNPs are simultaneously examined in GWAS, an extremely low P-value threshold may be employed for genome-wide significance, potentially leading to the omission of some marginally associated genes [43, 44] . However, considering that PD is a complex result of interactions between multiple genes and environmental factors and that the genetic backgrounds of the studied populations differ substantially, ethnicity-specific effects should be considered [45, 46] . Nevertheless, the present results suggested that the rs2241703 SNP may be a major or even the unique locus associated with PD in Chinese populations. Further studies involving a larger sample size of PD patients from different ethnic origins are needed to confirm these conclusions.
Some limitations of the present study should be acknowledged. We confirmed that SIRT2 is the target of miR-486-3p, and the rs2241703 SNP influences the binding efficiency between these molecules in vitro. Nevertheless, based on homology comparisons, the sequence in the miR-486-3p binding site of SIRT2 is not the same between humans and mice, and we therefore cannot further verify our conclusions in mice. However, we provide indirect evidence from human PBMCs to corroborate the relationship between SIRT2 and miR-486-3P. Furthermore, our aim in this study was to evaluate the rescue effect of miR-486-3P on the pathological process of PD, so miR-486-3P-mediated inhibition of the pathological process of PD was not addressed. In addition, although we recruited clinical samples over a significant length of time, the clinical sample size of PD patients was still not sufficiently large, and further replication studies in larger, independent populations are necessary to corroborate these results.
Conclusion
In summary, we reported for the first time a new risk-conferring polymorphism in the SIRT2 gene and explored a biological mechanism for this functional polymorphism. Through a hospital-based case-control study, we identified a significant association of the rs2241703 polymorphism located in the 3' UTR of the SIRT2 gene with PD in a Chinese Han population, and we provide further evidence showing that this SNP alters the binding efficiency of miR-486-3p to SIRT2, thereby affecting the expression level of SIRT2. In turn, miR-486-3p was shown to influence neurotoxicity through SIRT2 in a PD cell model and may ultimately contribute to the progression and risk of PD. In further studies, we will explore whether miR-486-3p and SIRT2 may be useful in the diagnosis of PD and therapeutic interventions for this disease.
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